Downloads: 8
Informative Article | Dermatology | Volume 11 Issue 5, May 2022 | Pages: 1818 - 1820 | India
Calcific Uremic Arteriolopathy (Calciphylaxis) Dermatological Case
Abstract: Introduction: Calciphylaxis, also known as calcific uraemic arteriolopathy (CUA), is a rare condition characterized by exquisitely painful necrotic ulcerations in patients with end-stage renal disease (ESRD) undergoing dialysis. Calcific uraemic arteriolopathy can be characterized by obstructive vasculopathy, with calcification of small arteries and arterioles resulting in luminal occlusion and subsequently cutaneous necrosis [1]. The incidence of CUA is estimated to be approximately 1% in patients with CKD and 4% in patients on dialysis [2]. The disease is rare but devastating, increasing in dialysis population [3] and its aetiology is still unmasked that is challenging demonstrates a challenge for different specialities. Even if diagnosed in early stages, the mortality rate remains exceptionally High and the success in healing is low. [4] Mortality rates are estimated at 60-80% [5]Furthermore, the disease is characterized by skin ulceration that undergo necrosis leading to intense pain and can be localized on any part of the skin. Objective: To raise awareness of Calciphylaxis in hopes of prompting earlier recognition with improved clinical outcomes. It is a rare complication but a fatal event of chronic kidney disease.
Keywords: Calcific Uremic Arteriolopathy, Calciphylaxis, Dermatology
How to Cite?: Dr. Nikhat, Dr. Sumera Huma, "Calcific Uremic Arteriolopathy (Calciphylaxis) Dermatological Case", Volume 11 Issue 5, May 2022, International Journal of Science and Research (IJSR), Pages: 1818-1820, https://www.ijsr.net/getabstract.php?paperid=SR22524002442, DOI: https://dx.doi.org/10.21275/SR22524002442